Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.